Rapid Subcutaneous IgG Replacement Therapy at Home for Pregnant Immunodeficient Women

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Immunology

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1011051704960PMID 11332654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin replacement therapy for common variable immunodeficiency during pregnancy

  2009cited by this paper
• The Comparison of the Efficacy and Safety of Intravenous Versus Subcutaneous Immunoglobulin Replacement Therapy

  2000cited by this paper
• Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy

  1996influential reference
• Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.

  1995cited by this paper
• Bioavailability of γ-globulin after subcutaneous infusions in patients with common variable immunodeficiency

  1994cited by this paper
• Bioavailability of gamma-globulin after subcutaneous infusions in patients with common variable immunodeficiency.

  1994cited by this paper
• Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature.

  1994cited by this paper
• Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature.

  1994cited by this paper
• Placental transfer of immunoglobulin G subclasses.

  1994cited by this paper
• Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.

  1991cited by this paper
• IgG Replacement therapy for primary hypogammaglobulinaemia during pregnancy: Report of 9 pregnancies in 4 patients

  1990cited by this paper
• Intravenous gamma-globulin in pregnancy: a review.

  1989influential reference
• Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy.

  1986cited by this paper
• Common variable hypogammaglobulinemia in pregnancy: Treatment with high‐dose immunoglobulin infusions

  1986cited by this paper
• Intravenous Immunoglobulin in Pregnancy

  1985cited by this paper
• Tubal pregnancy: significance of serum and peritoneal fluid alpha-amylase.

  1985cited by this paper
• Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.

  1984cited by this paper
• High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy.

  1982cited by this paper
• Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

  1966cited by this paper
• CHANGES IN THE BLOOD VOLUME DURING PREGNANCY AND DELIVERY.

  1965cited by this paper

• Pregnancy complications in women with an inborn error of immunity: a systematic review

  2025influential citation
• Late-stage placental barrier model for transport studies of prescription drugs during pregnancy.

  2025cites this paper
• Life-threatening infections in human newborns: Reconciling age-specific vulnerability and interindividual variability.

  2024cites this paper
• Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens

  2023cites this paper
• Primary Antibody Immunodeficiency and the Pregnant Patient.

  2022cites this paper
• Immunodeficiency Secondary to Prematurity, Pregnancy, and Aging

  2021cites this paper
• What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review

  2018influential citation
• Puberty, Menarche and Fertility

  2018cites this paper
• Primary Immunodeficiencies in Pregnancy

  2018cites this paper
• A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement

  2018cites this paper
• Pregnancy, child bearing and prevention of giving birth to the affected children in patients with primary immunodeficiency disease; a case-series

  2018cites this paper
• Update on the use of immunoglobulin in human disease: A review of evidence

  2017cites this paper
• II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies

  2017cites this paper
• Management of common variable immunodeficiency by subcutaneous IgG self‐administration during pregnancy – a case report

  2017cites this paper
• International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

  2016cites this paper
• Successful use of 20% subcutaneous immunoglobulin in pregnant women with primary immune deficiency.

  2016cites this paper
• Clinical experiences in primary and secondary immunodeficiencies and immune-mediated conditions using Gammanorm(®).

  2016cites this paper
• Successful use of 20% subcutaneous immunoglobulin in pregnant women with primary immune deficiency

  2016cites this paper
• Current Perspectives ICON : Common Variable Immunodeficiency Disorders

  2015cites this paper
• Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease

  2015cites this paper
• Fertility, Pregnancies and Outcomes Reported by Females with Common Variable Immune Deficiency and Hypogammaglobulinemia: Results from an Internet-Based Survey

  2015cites this paper
• Pregnancy Outcome in Patients with Common Variable Immunodeficiency

  2015cites this paper
• Does the Maternal Serum IgG Level during Pregnancy in Primary Antibody Deficiency Influence the IgG Level in the Newborn?

  2015cites this paper
• ICON: Common Variable Immunodeficiency Disorders

  2015cites this paper
• Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion

  2014cites this paper
• Chapter 56 – Immunoglobulin Replacement

  2014cites this paper
• Subcutaneous immunoglobulin replacement therapy: the European experience

  2013cites this paper
• Biologics: Targets and Therapy

  2013cites this paper
• Management of granulomatous common variable immunodeficiency diagnosed in pregnancy: a case report

  2012cites this paper
• Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.

  2012cites this paper
• Naturally occurring antibodies/autoantibodies in polyclonal immunoglobulin concentrates.

  2012cites this paper
• Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration

  2012cites this paper
• Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy.

  2012cites this paper
• Immunoglobulin Treatment for Primary Antibody Deficiencies

  2012cites this paper
• Naturally Occurring Antibodies (NAbs)

  2012cites this paper
• Utilización de inmunoglobulina subcutánea durante el embarazo en déficit humoral

  2011cites this paper
• Immunological Aspects of Human Reproduction

  2011cites this paper
• IgG Placental Transfer in Healthy and Pathological Pregnancies

  2011cites this paper
• [Subcutaneous immunoglobulin substitution and therapy].

  2011cites this paper
• Immunoglobulin treatment in primary antibody deficiency.

  2011cites this paper
• Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

  2010cites this paper
• Immune globulin subcutaneous (human), 20% liquid.

  2010cites this paper
• Dovepress Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency

  2009cites this paper
• Immune globulin subcutaneous (human) vivaglobin: for the treatment of primary immunodeficiency diseases.

  2009cites this paper
• Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin

  2009cites this paper
• Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear.

  2009cites this paper
• An update on treatment strategies for common variable immunodeficiency

  2009cites this paper
• Beyond the worst case scenario: ‘Managing’ the risks of extreme events

  2009cites this paper
• Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear

  2009cites this paper
• Dovepress Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency

  2009cites this paper
• Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy.

  2008cites this paper
• Immunoglobulin replacement therapy in children.

  2008cites this paper
• Subcutaneous administration of IgG.

  2008cites this paper
• Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.

  2008cites this paper
• Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.

  2007cites this paper
• Durchführung, Kontrolle, Kosten - Nutzenvergleich und Wirksamkeit der Behandlung primärer B-Zell-Defekte mit subkutaner Immunglobulin-Ersatztherapie. Retrospektive Analyse von 30 Patienten.

  2006cites this paper
• Subcutaneous Administrationof Immunoglobulin

  2006cites this paper
• Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies

  2006cites this paper
• Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens

  2005cites this paper
• Women with primary antibody deficiencies requiring IgG replacement therapy: their perception of prenatal care during pregnancy.

  2004cites this paper
• Subcutaneous immunoglobulin replacement in primary immunodeficiencies.

  2004cites this paper
• Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin.

  2003cites this paper
• Express subcutaneous IgG infusions: decreased time of delivery with maintained safety.

  2002cites this paper
• Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment.

  2002cites this paper
• Pregnancy and immunology: selected aspects.

  2002cites this paper
• Novel aspects of hypogammaglobulinemic states.

  2002cites this paper